Wednesday, August 16, 2017 12:09:21 PM
Pub. No.: WO/2016/154473 International Application No.: PCT/US2016/024079
Publication Date: 29.09.2016 International Filing Date: 24.03.2016
https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2016154473&recNum=4&maxRec=13&office=&prevFilter=&sortOption=Pub+Date+Desc&queryString=FP%3A%28oncosec%29&tab=PCT+Biblio
In Table 1 they include the following checkpoint targets:
CTLA-4, PD-1, PD-L1, LAG-3, TIM3, KIR, BTLA, A2aR, HVEM
Yes, they are indeed encoding checkpoint inhibitors on plasmids!
And then you have the relationship with researchers at Ku Leuven, working on DNA encoded monoclonal antibodies.
Recent ONCSQ News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 07:30:19 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM